Hemolytic uremic syndrome: pathogenesis and update of interventions
- Autores
- Palermo, Marina Sandra; Exeni, Ramón Alfonso; Fernández, Gabriela Cristina
- Año de publicación
- 2009
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- The typical form of hemolytic uremic syndrome (HUS) is the major complication of Shiga toxin-producing Escherichia coli infections. HUS is a critical health problem in Argentina since it is the main cause of acute renal failure in children and the second cause of chronic renal failure, accounting for 20% of renal transplants in children and adolescents in Argentina. Despite extensive research in the field, the mainstay of treatment for patients with HUS is supportive therapy, and there are no specific therapies preventing or ameliorating the disease course. In this review, we present the current knowledge about pathogenic mechanisms and discuss traditional and innovative therapeutic approaches, with special focus in Argentinean contribution. The hope that a better understanding of transmission dynamics and pathogenesis of this disease will produce better therapies to prevent the acute mortality and the long-term morbidity of HUS is the driving force for intensified research.
Fil: Palermo, Marina Sandra. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina
Fil: Exeni, Ramón Alfonso. Municipio de La Matanza. Hospital del Niño; Argentina
Fil: Fernández, Gabriela Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina - Materia
-
Escherichia Coli Infections
Hus
Fluid Therapy
Hemolitic Uremic Syndrome
Shiga Toxin
Argentina - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/55090
Ver los metadatos del registro completo
id |
CONICETDig_193ffe88ef1b3ece37226a3da6418dfd |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/55090 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Hemolytic uremic syndrome: pathogenesis and update of interventionsPalermo, Marina SandraExeni, Ramón AlfonsoFernández, Gabriela CristinaEscherichia Coli InfectionsHusFluid TherapyHemolitic Uremic SyndromeShiga ToxinArgentinahttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3The typical form of hemolytic uremic syndrome (HUS) is the major complication of Shiga toxin-producing Escherichia coli infections. HUS is a critical health problem in Argentina since it is the main cause of acute renal failure in children and the second cause of chronic renal failure, accounting for 20% of renal transplants in children and adolescents in Argentina. Despite extensive research in the field, the mainstay of treatment for patients with HUS is supportive therapy, and there are no specific therapies preventing or ameliorating the disease course. In this review, we present the current knowledge about pathogenic mechanisms and discuss traditional and innovative therapeutic approaches, with special focus in Argentinean contribution. The hope that a better understanding of transmission dynamics and pathogenesis of this disease will produce better therapies to prevent the acute mortality and the long-term morbidity of HUS is the driving force for intensified research.Fil: Palermo, Marina Sandra. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; ArgentinaFil: Exeni, Ramón Alfonso. Municipio de La Matanza. Hospital del Niño; ArgentinaFil: Fernández, Gabriela Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; ArgentinaFuture Drugs Ltd.2009-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/55090Palermo, Marina Sandra; Exeni, Ramón Alfonso; Fernández, Gabriela Cristina; Hemolytic uremic syndrome: pathogenesis and update of interventions; Future Drugs Ltd.; Expert review of anti-infective therapy; 7; 6; 12-2009; 697-7071478-72101744-8336CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/http://www.tandfonline.com/doi/full/10.1586/eri.09.49info:eu-repo/semantics/altIdentifier/doi/10.1586/eri.09.49info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:54:34Zoai:ri.conicet.gov.ar:11336/55090instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:54:35.29CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Hemolytic uremic syndrome: pathogenesis and update of interventions |
title |
Hemolytic uremic syndrome: pathogenesis and update of interventions |
spellingShingle |
Hemolytic uremic syndrome: pathogenesis and update of interventions Palermo, Marina Sandra Escherichia Coli Infections Hus Fluid Therapy Hemolitic Uremic Syndrome Shiga Toxin Argentina |
title_short |
Hemolytic uremic syndrome: pathogenesis and update of interventions |
title_full |
Hemolytic uremic syndrome: pathogenesis and update of interventions |
title_fullStr |
Hemolytic uremic syndrome: pathogenesis and update of interventions |
title_full_unstemmed |
Hemolytic uremic syndrome: pathogenesis and update of interventions |
title_sort |
Hemolytic uremic syndrome: pathogenesis and update of interventions |
dc.creator.none.fl_str_mv |
Palermo, Marina Sandra Exeni, Ramón Alfonso Fernández, Gabriela Cristina |
author |
Palermo, Marina Sandra |
author_facet |
Palermo, Marina Sandra Exeni, Ramón Alfonso Fernández, Gabriela Cristina |
author_role |
author |
author2 |
Exeni, Ramón Alfonso Fernández, Gabriela Cristina |
author2_role |
author author |
dc.subject.none.fl_str_mv |
Escherichia Coli Infections Hus Fluid Therapy Hemolitic Uremic Syndrome Shiga Toxin Argentina |
topic |
Escherichia Coli Infections Hus Fluid Therapy Hemolitic Uremic Syndrome Shiga Toxin Argentina |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
The typical form of hemolytic uremic syndrome (HUS) is the major complication of Shiga toxin-producing Escherichia coli infections. HUS is a critical health problem in Argentina since it is the main cause of acute renal failure in children and the second cause of chronic renal failure, accounting for 20% of renal transplants in children and adolescents in Argentina. Despite extensive research in the field, the mainstay of treatment for patients with HUS is supportive therapy, and there are no specific therapies preventing or ameliorating the disease course. In this review, we present the current knowledge about pathogenic mechanisms and discuss traditional and innovative therapeutic approaches, with special focus in Argentinean contribution. The hope that a better understanding of transmission dynamics and pathogenesis of this disease will produce better therapies to prevent the acute mortality and the long-term morbidity of HUS is the driving force for intensified research. Fil: Palermo, Marina Sandra. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina Fil: Exeni, Ramón Alfonso. Municipio de La Matanza. Hospital del Niño; Argentina Fil: Fernández, Gabriela Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina |
description |
The typical form of hemolytic uremic syndrome (HUS) is the major complication of Shiga toxin-producing Escherichia coli infections. HUS is a critical health problem in Argentina since it is the main cause of acute renal failure in children and the second cause of chronic renal failure, accounting for 20% of renal transplants in children and adolescents in Argentina. Despite extensive research in the field, the mainstay of treatment for patients with HUS is supportive therapy, and there are no specific therapies preventing or ameliorating the disease course. In this review, we present the current knowledge about pathogenic mechanisms and discuss traditional and innovative therapeutic approaches, with special focus in Argentinean contribution. The hope that a better understanding of transmission dynamics and pathogenesis of this disease will produce better therapies to prevent the acute mortality and the long-term morbidity of HUS is the driving force for intensified research. |
publishDate |
2009 |
dc.date.none.fl_str_mv |
2009-12 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/55090 Palermo, Marina Sandra; Exeni, Ramón Alfonso; Fernández, Gabriela Cristina; Hemolytic uremic syndrome: pathogenesis and update of interventions; Future Drugs Ltd.; Expert review of anti-infective therapy; 7; 6; 12-2009; 697-707 1478-7210 1744-8336 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/55090 |
identifier_str_mv |
Palermo, Marina Sandra; Exeni, Ramón Alfonso; Fernández, Gabriela Cristina; Hemolytic uremic syndrome: pathogenesis and update of interventions; Future Drugs Ltd.; Expert review of anti-infective therapy; 7; 6; 12-2009; 697-707 1478-7210 1744-8336 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/http://www.tandfonline.com/doi/full/10.1586/eri.09.49 info:eu-repo/semantics/altIdentifier/doi/10.1586/eri.09.49 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Future Drugs Ltd. |
publisher.none.fl_str_mv |
Future Drugs Ltd. |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613657028198400 |
score |
13.070432 |